Update
$Ocugen(OCGN.US$ Ocugen, Inc. Announces U.S. FDA Clearance of IND Amendment to Initiate OCU400 Phase 3 Clinical Trial — First Gene Therapy to Enter Phase 3 with a Broad Retinitis Pigmentosa Indication
4 MINUTES AGO, 6:30 AM EDT
VIA GLOBENEWSWIRE
4 MINUTES AGO, 6:30 AM EDT
VIA GLOBENEWSWIRE
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
dSuu : I'm in for a run.. gl and gm
TrytosaveabitOP dSuu: Gl and GM to you! Thanks